Alkeon Capital Management - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$41,588,000
-15.0%
626,046
-0.2%
0.07%
-2.8%
Q2 2021$48,943,000
-17.7%
627,313
-0.3%
0.07%
-18.2%
Q1 2021$59,504,000
-22.2%
629,069
+0.2%
0.09%
-29.6%
Q4 2020$76,516,000
+83.6%
627,951
+31.6%
0.12%
+62.3%
Q3 2020$41,671,000
+35.3%
477,0000.0%0.08%
-1.3%
Q2 2020$30,810,000
+51.0%
477,000
+4.4%
0.08%
-10.3%
Q1 2020$20,410,000
-8.2%
457,000
+28.0%
0.09%
+4.8%
Q4 2019$22,238,000
+6.2%
357,000
-35.9%
0.08%
+12.2%
Q3 2019$20,943,000
-7.6%
557,0000.0%0.07%
-17.8%
Q2 2019$22,670,000557,0000.09%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q4 2021.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders